American Heart Association. Drug Therapy for Cholesterol. Available at: www.heart.org/HEARTORG/Conditions/Cholesterol/PreventionTreatmentofHighCholesterol/Drug-Therapy-for-Cholesterol_UCM_305632_Article.jsp. Accessed April 4, 2014.
Genest J, Libby P. Lipoprotein Disorders and Cardiovascular Disease. In: Bonow RO, Mann DL, Zipes DP, Libby P, eds.Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine
Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz N, Lloyd-Jones DM, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiolwww.ncbi.nlm.nih.gov/pubmed/24239923
U.S. Food and Drug Administration. FDA Drug Safety Communication: Review update of Trilipix (fenofibric acid) and the ACCORD Lipid trial. Available at: www.fda.gov/Drugs/DrugSafety/ucm278837.htm. Accessed April 4, 2014.
: 
Carmen Martínez, portavoz del Grupo Socialista en la Comisión de Sanidad del Congreso de los Diputados: 
Margarita de la Pisa, eurodiputada de Vox.: 
Ion Arocena, director general de la Asociación Española de Bioempresas (Asebio): 
Javier Padilla, secretario de Estado de Sanidad: